Starling Oncology, Inc. SEC filings STLN
Starling Oncology, Inc. has 544 filings in SEC EDGAR's recent list, going back to Jan 14, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | Jun 18, 2025 | — |
| CORRESP | Letter to the SEC | Jun 16, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 12, 2025 | — |
| EFFECT | Filing | May 16, 2025 | — |
| CORRESP | Letter to the SEC | May 14, 2025 | — |
| UPLOAD | Letter from the SEC | May 14, 2025 | — |
| D | Filing | Apr 8, 2025 | — |
| UPLOAD | Letter from the SEC | Jun 3, 2024 | — |
| CORRESP | Letter to the SEC | May 22, 2024 | — |
| UPLOAD | Letter from the SEC | May 15, 2024 | — |
| EFFECT | Filing | Feb 9, 2023 | — |
| EFFECT | Filing | Feb 9, 2023 | — |
| EFFECT | Filing | Jan 6, 2023 | — |
| EFFECT | Filing | Sep 26, 2022 | — |
| D | Filing | Aug 24, 2022 | — |
| EFFECT | Filing | Jun 3, 2022 | — |
| EFFECT | Filing | May 3, 2022 | — |
| EFFECT | Filing | Feb 11, 2022 | — |
| CORRESP | Letter to the SEC | Feb 9, 2022 | — |
| CORRESP | Letter to the SEC | Jan 4, 2022 | — |
| CORRESP | Letter to the SEC | Jan 3, 2022 | — |
| UPLOAD | Letter from the SEC | Dec 21, 2021 | — |
| 25-NSE | Delisting notice | Nov 12, 2021 | — |
| EFFECT | Filing | Oct 22, 2021 | — |
| 425 | Filing | Oct 22, 2021 | — |
| CORRESP | Letter to the SEC | Oct 21, 2021 | — |
| CORRESP | Letter to the SEC | Oct 20, 2021 | — |
| UPLOAD | Letter from the SEC | Oct 18, 2021 | — |
| 425 | Filing | Oct 12, 2021 | — |
| CORRESP | Letter to the SEC | Oct 1, 2021 | — |
| UPLOAD | Letter from the SEC | Sep 24, 2021 | — |
| CORRESP | Letter to the SEC | Sep 3, 2021 | — |
| UPLOAD | Letter from the SEC | Aug 30, 2021 | — |
| 425 | Form 8-k | Jun 29, 2021 | — |
| 425 | Filing | Jun 28, 2021 | — |
| NT 10-Q | Form nt 10-q | May 18, 2021 | Mar 31, 2021 |
| EFFECT | Filing | Mar 10, 2020 | — |
| CERT | Filing | Mar 10, 2020 | — |
| 8-A12B | Filing | Mar 10, 2020 | — |
| DRS | Filing | Jan 14, 2020 | — |
Showing 40 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Offices & Clinics of Doctors of Medicine (SIC 8011)
- Listed as
- STLN (Nasdaq), DFPH (OTC), STLNW (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cerritos, CA
- SEC filer status
- Accelerated filer, Smaller reporting company
- SEC CIK
- 1799191
- Former names
- Oncology Institute, Inc. (until Aug 3, 2026); DFP HEALTHCARE ACQUISITIONS CORP. (until Nov 12, 2021)
Other Services-Offices & Clinics of Doctors of Medicine companies
- Hims & Hers Health, Inc. HIMS
- Teladoc Health, Inc. TDOC
- SBC Medical Group Holdings Inc SBC
- Auna S.A. AUNA
- Airsculpt Technologies, Inc. AIRS
- LifeMD, Inc. LFMD
- Westin Acquisition Corp WSTN
- Basel Medical Group Ltd BMGL
All 12 Services-Offices & Clinics of Doctors of Medicine companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.